Maria Luz Morales (María Luz Morales)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Top Venues

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ernesto José Cuenca-Zamora, Pedro J Guijarro-Carrillo, María J López-Poveda, Maria Luz Morales, María Luisa Lozano, Rocío González-Conejero, Constantino Martínez, Raul Teruel-Montoya, Francisca Ferrer-Marín
miR-146a -/- mice model reveals that NF-κB inhibition reverts inflammation-driven myelofibrosis-like phenotype. American journal of hematology 99 (7) (2024)
Ernesto José Cuenca-Zamora, Pedro J Guijarro-Carrillo, María J López-Poveda, Maria Luz Morales, María Luisa Lozano, Rocío González-Conejero, Constantino Martínez, Raul Teruel-Montoya, Francisca Ferrer-Marín
miR-146a -/- mice model reveals that NF-κB inhibition reverts inflammation-driven myelofibrosis-like phenotype. American journal of hematology (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Ernesto José Cuenca-Zamora, Pedro J Guijarro-Carrillo, María J López-Poveda, Maria Luz Morales, María Luisa Lozano, Rocío González-Conejero, Constantino Martínez, Raul Teruel-Montoya, Francisca Ferrer-Marín
miR-146a -/- mice model reveals that NF-κB inhibition reverts inflammation-driven myelofibrosis-like phenotype. American journal of hematology 99 (7) (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Maria Luz Morales, Francisca Ferrer-Marín
Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? Cancers 15 (4) (2023)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-chain fatty acid production by gut microbiota predicts treatment response in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maria Luz Morales, Francisca Ferrer-Marín
Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? Cancers 15 (4) (2023)
Maria Luz Morales, Roberto García-Vicente, Alba Rodríguez-García, Armando Reyes-Palomares, África Vincelle-Nieto, Noemí Álvarez, Alejandra Ortiz-Ruiz, Vanesa Garrido-García, Alicia Giménez, Gonzalo Carreno-Tarragona, Ricardo Sanchez, Rosa Ayala, Joaquin Martinez Lopez, María Linares
Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia. Leukemia (2023)
Maria Luz Morales, Francisca Ferrer-Marín
Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? Cancers 15 (4) (2023)
Gonzalo Carreno-Tarragona, Alberto Alvarez-Larran, Claire N Harrison, Jose Carlos Martínez Ávila, Juan Carlos Carlos Hernández-Boluda, Francisca Ferrer-Marín, Deepti H Radia, Elvira Mora Casterá, Sebastian Francis, Teresa González-Martínez, Kathryn Goddard, Manuel Mateo Pérez Encinas, Srinivasan Narayanan, Jose Maria Raya, Vikram Singh, Peter Toth, Xabier Gutiérrez, Paula Amat Martinez, Louisa McIlwaine, Magda Alobaidi, Karan Mayani, Andrew McGregor, Ruth Stuckey, Bethan Psaila, Adrian Segura, Caroline L Alvares, Kerri Davidson, Santiago Osorio, Robert Cutting, Caroline P Sweeney, Laura Rufian, Laura Moreno, Isabel Cuenca, Jeffrey Smith, Maria Luz Morales, Rodrigo Gil-Manso, Ioannis Koutsavlis, Lihui Wang, Adam J Mead, Maria Rozman, Joaquin Martínez-López, Rosa María Ayala, Nicholas C P Cross
CNL and aCML should be considered as single entity based on molecular profiles and outcomes. Blood advances (2022)
Raquel Ancos-Pintado, Irene Bragado-García, Maria Luz Morales, Roberto García-Vicente, Andrés Arroyo-Barea, Alba Rodríguez-García, Joaquin Martinez Lopez, María Linares, María Hernández-Sánchez
High-Throughput CRISPR Screening in Hematological Neoplasms. Cancers 14 (15) (2022)
Pilar Carreras, Itziar González, Miguel Gallardo, Alejandra Ortiz-Ruiz, Maria Luz Morales, Jessica Encinas, Joaquin Martinez Lopez
Long-Term Human Hematopoietic Stem Cell Culture in Microdroplets. Micromachines 12 (1) (2021)
Alba Rodríguez-García, Roberto García-Vicente, Maria Luz Morales, Alejandra Ortiz-Ruiz, Joaquin Martinez Lopez, María Linares
Protein Carbonylation and Lipid Peroxidation in Hematological Malignancies. Antioxidants (Basel, Switzerland) 9 (12) (2020)
Alba Rodríguez-García, Maria Luz Morales, Vanesa Garrido-García, Irene García-Baquero, Alejandra Leivas, Gonzalo Carreño-Tarragona, Ricardo Sanchez, Alicia Arenas, María-Teresa Cedena, Rosa María Ayala, José M Bautista, Joaquín Martínez-López, María Linares
Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy. Antioxidants (Basel, Switzerland) 8 (11) (2019)
Maria Luz Morales, Alicia Arenas, Alejandra Ortiz-Ruiz, Alejandra Leivas, Inmaculada Rapado, Alba Rodríguez-García, Nerea Castro, Ivana Zagorac, Miguel Quintela-Fandino, Gonzalo Gómez-López, Miguel Gallardo, Rosa Ayala, María Linares, Joaquín Martínez-López
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia. Scientific reports 9 (1) (2019)